Literature DB >> 20661412

Matrix metalloproteinase-1 expression in splenic angiosarcoma metastasizing to the serous membrane.

Tamotsu Takeuchi1, Shinji Iwasaki, Junichi Miyazaki, Yasuko Nozaki, Masaya Takahashi, Masafumi Ono, Toshiji Saibara, Mutsuo Furihata.   

Abstract

Angiosarcoma involving the serous membrane may mimic mesothelioma; therefore, the term "pseudomesotheliomatous angiosarcoma" has been suggested for this entity. However, the pathogenesis of pseudomesotheliomatous angiosarcoma remains unclear. Here, we report an autopsy case of splenic angiosarcoma, which systemically metastasized to the serous membrane of both the peritoneum and pleura, closely resembling a mesothelioma. The spindle-shaped tumor cells exhibited marked invasion of the lymphatic vessels and invaded the serous membrane causing thickening of the fibrous tissues like desmoplastic mesothelioma. In the present case, immunohistochemical staining showed that the tumor expressed not only the endothelial cell markers, such as CD31, vascular endothelial growth factor receptor 3, and podoplanin (D2-40), but also matrix metalloproteinase-1 (also known as collagenase-1), which is known to increase the invasiveness of mesothelioma cells. MMP-1 expression was not observed in the other cases of angiosarcoma, examined. This tumor might systemically metastasize to the serous membrane via the lymphatic route and might generate the fibrous stroma aided by the matrix metalloproteinase-1.

Entities:  

Keywords:  Angiosarcoma; MMP-1; collagenase-1; pseudomesothelioma

Mesh:

Substances:

Year:  2010        PMID: 20661412      PMCID: PMC2907126     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  Expression of T-cadherin (CDH13, H-Cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells.

Authors:  T Takeuchi; A Misaki; S B Liang; A Tachibana; N Hayashi; H Sonobe; Y Ohtsuki
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

2.  Pseudomesotheliomatous carcinoma of the lung. A variant of peripheral lung cancer.

Authors:  T R Harwood; D R Gracey; H Yokoo
Journal:  Am J Clin Pathol       Date:  1976-02       Impact factor: 2.493

3.  Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters.

Authors:  Barbara Kroczynska; Rochelle Cutrone; Maurizio Bocchetta; Haining Yang; Amira G Elmishad; Pamela Vacek; Maria Ramos-Nino; Brooke T Mossman; Harvey I Pass; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

4.  Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.

Authors:  Z Liu; A Ivanoff; J Klominek
Journal:  Int J Cancer       Date:  2001-03-01       Impact factor: 7.396

5.  Unusual thoracic manifestations of epithelioid hemangioendothelioma.

Authors:  S A Yousem; L Hochholzer
Journal:  Arch Pathol Lab Med       Date:  1987-05       Impact factor: 5.534

6.  Angiosarcoma of skin and soft tissue: a study of forty-four cases.

Authors:  J C Maddox; H L Evans
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

7.  Interstitial collagenase is a Brownian ratchet driven by proteolysis of collagen.

Authors:  Saveez Saffarian; Ivan E Collier; Barry L Marmer; Elliot L Elson; Gregory Goldberg
Journal:  Science       Date:  2004-10-01       Impact factor: 47.728

8.  Angiosarcoma of serous membranes.

Authors:  W T McCaughey; I Dardick; J R Barr
Journal:  Arch Pathol Lab Med       Date:  1983-06       Impact factor: 5.534

9.  An autopsy case of primary angiosarcoma of the pericardium mimicking malignant mesothelioma.

Authors:  T Terada; Y Nakanuma; T Matsubara; T Suematsu
Journal:  Acta Pathol Jpn       Date:  1988-10

10.  [Malignant angioblastic mesothelioma of the pericardium (author's transl)].

Authors:  H Höfler; P Schmid; K H Tscheliessnigg
Journal:  Zentralbl Allg Pathol       Date:  1979
View more
  7 in total

1.  Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate.

Authors:  Masaya Ishibashi; Taku Fujimura; Akira Hashimoto; Takahiro Haga; Kaoru Onami; Akira Tsukada; Yumi Kambayashi; Takanori Hidaka; Sadanori Furudate; Ryoko Shimada; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-01-11

2.  The role of podoplanin in the biology of differentiated thyroid cancers.

Authors:  Magdalena Rudzińska; Damian Gaweł; Justyna Sikorska; Kamila M Karpińska; Mirosław Kiedrowski; Tomasz Stępień; Magdalena Marchlewska; Barbara Czarnocka
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

3.  Demanding Diagnosis of Splenic Angiosarcoma as Cause of Delayed Treatment of Spontaneous Splenic Rupture: A Case Report and Literature Review.

Authors:  Sara Coppola; Andrea Leva; Fabio Pagni; Simone Famularo; Luca Gianotti
Journal:  Case Rep Surg       Date:  2017-02-02

4.  Role of matrix metalloproteinases in tumour invasion: immunohistochemistry of peritoneum from peritoneal carcinomatosis.

Authors:  Peter Falk; Andreas Jonsson; Torbjörn Swartling; Dan Asplund; Marie-Lois Ivarsson
Journal:  Med Oncol       Date:  2018-04-05       Impact factor: 3.064

5.  Hemoptoe, thin-walled lung cysts, and spontaneous pneumothorax are features of metastatic cutaneous angiosarcoma : A case report.

Authors:  Iurii Mykoliuk; Martin Zacharias; Oliver Sankin; Jörg Lindenmann; Freyja-Maria Smolle-Juettner
Journal:  Wien Med Wochenschr       Date:  2022-05-11

6.  Systemic therapy in primary angiosarcoma of the spleen.

Authors:  Bruna Pellini Ferreira; Eve T Rodler; Elizabeth T Loggers; Seth M Pollack; Robin L Jones
Journal:  Rare Tumors       Date:  2012-11-13

7.  Extracellular matrix composition modulates angiosarcoma cell attachment and proliferation.

Authors:  Noel L Shaheen; Esha Kataria; Jocelyn Antony; Dana Galvan; Yessenia Ballou; Brad A Bryan
Journal:  Oncoscience       Date:  2017-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.